204 related articles for article (PubMed ID: 22834684)
1. Evolving pharmacological approaches in gastroesophageal reflux disease.
Altan E; Blondeau K; Pauwels A; Farré R; Tack J
Expert Opin Emerg Drugs; 2012 Sep; 17(3):347-59. PubMed ID: 22834684
[TBL] [Abstract][Full Text] [Related]
2. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.
Johnson DA; Levy BH
Expert Opin Pharmacother; 2010 Jun; 11(9):1541-8. PubMed ID: 20450445
[TBL] [Abstract][Full Text] [Related]
3. A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD).
Savarino E; Zentilin P; Marabotto E; Bodini G; Della Coletta M; Frazzoni M; de Bortoli N; Martinucci I; Tolone S; Pellegatta G; Savarino V
Expert Opin Pharmacother; 2017 Sep; 18(13):1333-1343. PubMed ID: 28754071
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological management of GERD: where does it stand now?
Hershcovici T; Fass R
Trends Pharmacol Sci; 2011 Apr; 32(4):258-64. PubMed ID: 21429600
[TBL] [Abstract][Full Text] [Related]
5. New pharmacologic approaches in gastroesophageal reflux disease.
Armstrong D; Sifrim D
Gastroenterol Clin North Am; 2010 Sep; 39(3):393-418. PubMed ID: 20951909
[TBL] [Abstract][Full Text] [Related]
6. New pharmacological agents for the treatment of gastroesophageal reflux disease.
Vakil N
Rev Gastroenterol Disord; 2008; 8(2):117-22. PubMed ID: 18641594
[TBL] [Abstract][Full Text] [Related]
7. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
Watson TJ; Peters JH
Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
[TBL] [Abstract][Full Text] [Related]
8. Reflux inhibitors: a new approach for GERD?
Boeckxstaens GE
Curr Opin Pharmacol; 2008 Dec; 8(6):685-9. PubMed ID: 18771751
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors: the beginning of the end or the end of the beginning?
Scarpignato C; Hunt RH
Curr Opin Pharmacol; 2008 Dec; 8(6):677-84. PubMed ID: 18840545
[TBL] [Abstract][Full Text] [Related]
10. Medical treatments of GERD: the old and new.
Vela MF
Gastroenterol Clin North Am; 2014 Mar; 43(1):121-33. PubMed ID: 24503363
[TBL] [Abstract][Full Text] [Related]
11. Recent developments in the pathophysiology and therapy of gastroesophageal reflux disease and nonerosive reflux disease.
Tack J
Curr Opin Gastroenterol; 2005 Jul; 21(4):454-60. PubMed ID: 15930988
[TBL] [Abstract][Full Text] [Related]
12. Medical treatment of GORD. Emerging therapeutic targets and concepts.
Zerbib F
Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):937-46. PubMed ID: 21126705
[TBL] [Abstract][Full Text] [Related]
13. Emerging drugs for gastroesophageal reflux disease.
Boeckxstaens GE
Expert Opin Emerg Drugs; 2009 Sep; 14(3):481-91. PubMed ID: 19650746
[TBL] [Abstract][Full Text] [Related]
14. Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors.
Hershcovici T; Fass R
Curr Opin Gastroenterol; 2010 Jul; 26(4):367-78. PubMed ID: 20571388
[TBL] [Abstract][Full Text] [Related]
15. One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center.
Bonavina L; Saino G; Bona D; Sironi A; Lazzari V
J Am Coll Surg; 2013 Oct; 217(4):577-85. PubMed ID: 23856355
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
Higginbotham TW
Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
[TBL] [Abstract][Full Text] [Related]
17. Lesogaberan, a GABA(B) agonist for the potential treatment of gastroesophageal reflux disease.
Bredenoord AJ
IDrugs; 2009 Sep; 12(9):576-84. PubMed ID: 19697277
[TBL] [Abstract][Full Text] [Related]
18. Novel treatments of GERD: focus on the lower esophageal sphincter.
Lehmann A
Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():103-10. PubMed ID: 18924449
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of lesogaberan in gastro-oesophageal reflux disease: a randomised controlled trial.
Shaheen NJ; Denison H; Björck K; Karlsson M; Silberg DG
Gut; 2013 Sep; 62(9):1248-55. PubMed ID: 22730470
[TBL] [Abstract][Full Text] [Related]
20. Treatment of gastro-esophageal reflux disease: the new kids to block.
Blondeau K
Neurogastroenterol Motil; 2010 Aug; 22(8):836-40. PubMed ID: 20663054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
